What is blood cancer?
Blood cancer is a type of cancer that affects your blood cells. DNA mutations are the main cause of blood cancers.
Leukaemia & Lymphoma NI is the only charity in NI dedicated to research into developing life-saving new treatments for Blood Cancers.
All money remains in NI to fund work carried out here by the Blood Cancer Group at the Patrick G Johnston Centre for Cancer Research near Belfast City Hospital.
Blood cancer is a type of cancer that affects your blood cells. DNA mutations are the main cause of blood cancers.
There are many organisations that offer support services for blood cancer patients.
Leukaemia & Lymphoma NI provide funding for a Blood Cancer Patient Supporter who works in the Bridgewater Suite at Belfast City Hospital and at Antrim hospital, as well as funding a Clinical Trials Nurse based in BCH.
Since 1964 we have been raising money to support local researchers and the science behind helping improve treatments and outcomes for blood cancer patients in NI.
Find Out MoreWe want to hear from you. We have collaborated with people who have been diagnosed with blood cancer, to share their story and their experience after diagnosis.
diagnosed every year in NI
diagnosed every year in the UK
Patron of LLNI, former UTV broadcaster, Ken Reid proudly supports our work:
“When you regularly visit the Bridgewater Suite for cancer patients at City Hospital like I have, you get to know the doctors, nurses and your fellow patients. I’ve seen people have their conditions turned around thanks to treatments that were not available as recently as five or ten years ago.
“Leukaemia & Lymphoma NI are funding research and trials which are quite literally life changing. It’s work that deserves our support because the statistics around blood cancer in Northern Ireland are alarming, but the track record of research shows that our brilliant medical scientists, clinicians, doctors and nurses are finding solutions.”
We fund world-class innovative projects here in Belfast that not only have an impact on local patient treatments and outcomes, but are also shared with the global blood cancer community.